Physician profile
Dawn C Malcom
NPI 1215439690
$741.94
in general payments reported to CMS, 2019-2025
11 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $180 · 2023: $92.78 · 2024: $180 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $223.69 | 2023-2025 | Breztri, Airsupra |
| Regeneron Healthcare Solutions, INC. | $120.69 | 2022-2024 | Evkeeza |
| Supernus Pharmaceuticals, INC. | $80.52 | 2022 | |
| Dexcom, INC. | $80.50 | 2024-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $65.50 | 2023-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $54.45 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.20 | 2024-2025 | Jardiance |
| Abbott Laboratories | $22.55 | 2024 | Freestyle Libre |
| Dynavax Technologies Corporation | $22.10 | 2023 | Heplisav-B |
| Exact Sciences Corporation | $19.31 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $17.43 | 2024 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Malcom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.